TGA Approval

CAMZYOS mavacamten 5 mg capsule blister pack (386128)

ARTG ID

386128

ARTG Name

CAMZYOS mavacamten 5 mg capsule blister pack

Sponsor

Bristol-Myers Squibb Australia Pty Ltd

ARTG Date

September 19, 2022

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

BRISTOL-MYERS SQUIBB AUSTRALIA PTY LTD

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-CMI-02454-1

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-PI-02048-1

Ingredient Name

mavacamten

Empowering clinical research with data-driven insights and AI-powered tools.

CAMZYOS mavacamten 5 mg capsule blister pack (386128) - TGA 批准文号 | MedPath